New England Research & Management Inc. Has $494,000 Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

New England Research & Management Inc. lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 73.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,438 shares of the company's stock after selling 15,215 shares during the period. New England Research & Management Inc.'s holdings in GE HealthCare Technologies were worth $494,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the business. Rise Advisors LLC increased its stake in shares of GE HealthCare Technologies by 241.4% during the first quarter. Rise Advisors LLC now owns 338 shares of the company's stock valued at $31,000 after acquiring an additional 239 shares during the period. Riverview Trust Co acquired a new position in shares of GE HealthCare Technologies during the first quarter valued at approximately $31,000. Fortitude Family Office LLC acquired a new position in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $29,000. Turtle Creek Wealth Advisors LLC acquired a new position in GE HealthCare Technologies in the fourth quarter worth approximately $30,000. Finally, Sachetta LLC acquired a new position in GE HealthCare Technologies in the fourth quarter worth approximately $31,000. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Trading Down 1.1 %

NASDAQ GEHC traded down $0.90 on Friday, hitting $77.92. 9,422,475 shares of the stock were exchanged, compared to its average volume of 2,701,271. The company's 50-day moving average price is $79.85 and its two-hundred day moving average price is $81.80. The company has a market capitalization of $35.57 billion, a price-to-earnings ratio of 22.78, a P/E/G ratio of 2.83 and a beta of 1.22. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.06 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.90. The company had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.80 billion. GE HealthCare Technologies had a net margin of 8.05% and a return on equity of 25.32%. The company's revenue for the quarter was down 1.2% on a year-over-year basis. During the same quarter last year, the business posted $0.85 EPS. Research analysts predict that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be paid a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. The ex-dividend date is Friday, July 19th. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.51%.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, insider Frank R. Jimenez acquired 1,315 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, May 1st. The stock was acquired at an average price of $76.52 per share, with a total value of $100,623.80. Following the purchase, the insider now owns 75,796 shares in the company, valued at $5,799,909.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CTO Taha Kass-Hout sold 3,300 shares of GE HealthCare Technologies stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total value of $259,710.00. Following the completion of the sale, the chief technology officer now owns 67,300 shares of the company's stock, valued at approximately $5,296,510. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Frank R. Jimenez acquired 1,315 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, May 1st. The stock was acquired at an average cost of $76.52 per share, with a total value of $100,623.80. Following the purchase, the insider now owns 75,796 shares in the company, valued at approximately $5,799,909.92. The disclosure for this purchase can be found here. Insiders sold 90,482 shares of company stock valued at $7,369,137 in the last quarter. Company insiders own 0.27% of the company's stock.

Analyst Ratings Changes

GEHC has been the topic of several recent research reports. Mizuho decreased their price target on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a "buy" rating on the stock in a research report on Wednesday, May 1st. Evercore ISI lifted their price target on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an "outperform" rating in a research report on Thursday, April 4th. The Goldman Sachs Group initiated coverage on shares of GE HealthCare Technologies in a research report on Thursday, May 30th. They issued a "neutral" rating and a $87.00 price target on the stock. Bank of America decreased their price target on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 1st. Finally, Citigroup lifted their price target on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a "buy" rating in a research report on Wednesday, April 3rd. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $94.09.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.